SERVICES
Go To Market
Our consultancy firm offers specialized services to optimize early-stage platforms across diverse sectors. Utilizing Lean Start Up methodologies, we swiftly identify promising sectors. From market opportunity assessments to cost/benefit studies and pricing research, we provide invaluable insights to inform strategic decision-making.

In our experience early stage platforms can be used across multiple industrial sectors.
However, it is critical to identify the most promising sector and application for its first use due to the typical financial constraints of private/public funding.
Using Lean StartUp methodologies the most promising sectors and applications can be rapidly identified. In addition, a contrast is made between the technology and the large and medium-sized companies in the health sector. The contrast is made with 20 companies previously agreed with client.
+34 644 18 70 08
info@ituahealth.com

Elaboration of market studies based on bibliographical data and a profound study of epidemiological data, unmet market needs, strategic positioning and competitive landscape. Includes the validation of the technology through interviews with final clients and/or industrial partners.
Additionally, sales forecasts for the products can be elaborated again based on epidemiological models. The market quotas are based on the scientific data obtained to date.
+34 644 18 70 08
info@ituahealth.com

We can quantify the savings for the health systems of implementing the project using systematic proprietary methods for quantifying and comparing the total costs to the total expected rewards of undertaking the project or making the investment. We accommodate real world uncertainty into our proprietary NPV valuation model and incorporate Monte Carlo simulations for virtually every assumption. This results in a range of valuations which is more realistic, and informative, than a single number. Our analysis also identifies which assumptions are contributing most to the uncertainty in the model
These studies may be critical for the execution of a license or investment, and to position the product withon the healthcare system.
+34 644 18 70 08
info@ituahealth.com

With our pricing studies you will know what exact price your product or service should have so that it is viable in the market and can be profitable for your business. We will do a complete study of the market, we will know what is sold, at what price it is sold, how successful it is and where the space is for your product or service. Each case is different, the market is variable, trends are very unstable and a deep knowledge of the market is necessary to minimize risks as much as possible.
Pricing studies enable the simulations on the demand of variations in price enabling you to determine what price the target audience is willing to pay for the product.
Pricing studies enables the simulations on the demand of variations in price enabling you to determine what price the target audience is willing to pay for the product.
+34 644 18 70 08
info@ituahealth.com

It is essential to select the first therapeutic indication of the developed molecule since the company’s business plan will need to contemplate it with an impact on the investment raised. Furthermore, VCs invest in concrete indications that are already outlined.
Also the regulation of the drug is specific to the indication and financial resources are limited so it is essential to have a clear roadmap.
+34 644 18 70 08
info@ituahealth.com
High impact health and biotechnology consulting services that drive disruptive technologies with agility to speed innovation and improve outcomes.
We excel in evaluating and expediting early-stage technologies, with a focus on optimizing their commercialization through licensing or start-up creation.
2024 All rights reserved – LEGAL ADVISE | COOKIES | PRIVACITY POLICY